CDH1 and endometrial cancer: The Hec50 and AN3CA cell lines represent aggressive type 2 endometrial cancers that have lost epithelial markers including E-cadherin and ESR1 and gained mesenchymal markers such as N-cadherin and vimentin, indicative of EMT.